1879 Impact of adjuvant trastuzumab (adjT) for early-stage (ES) breast cancer (BC) on clinical characteristics, survival and likelihood of durable complete response (DCR) of HER2-positive (HER2+) metastatic breast cancer (MBC): A 15-year single-institution cohort study. (September 2015)

• Record Type: Journal Article
• Authors: Zacchia, A.; Gullo, G.; Parker, I.; De Giorgi, A.; Fennelly, D.; Zanoni, D.; Walshe, J.; Defrein, A.M.; Quinn, C.; Silva, N.; O' Donovan, N.; Ballot, J.; Mc Dermott, E.; Crown, J.
• Is Part Of: European journal of cancer. Volume 51:(2015)Supplement 3
• Page Start: S292
• Page End: S293
• Publication Date: 2015-09
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(16)30829-2
• Languages: English
• ISSNs: 0959-8049